Ex vivo modulation of RANTES and sCD30 by proinflammatory stimuli in HIV-seropositive and -negative individuals

Clinical Immunology

Volumn 97, Issue 2, 2000, Pages 102-108

  Delfanti, Fanny ^a   Veglia, Fabrizio ^b   Poli, Guido ^a   Lazzarin, Adriano ^a   Biswas, Priscilla ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ISI FOUNDATION   (Italy)

Author keywords

Ex vivo; HIV; RANTES; sCD30

Indexed keywords

CD30 ANTIGEN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; RANTES;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSTIMULATION; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SERODIAGNOSIS;

EID: 0033769793     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4923     Document Type: Article

References (50)

1. Host factors and the pathogenesis of HIV-induced disease
2. Prognostic significance of immune activation, HIV viral load and CD4 T-cell measurements
3. Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection
4. Inflammatory cytokines and inhibitors in HIV infection: Correlation between interleukin-1 receptor antagonist and weight loss
5. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients
6. Cytokine patterns in adults with AIDS
7. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
8. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
9. Ki-1 (CD30) antigen is released by Ki-1 positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzime-linked-immunosorbent-assay
10. Plasma levels of soluble CD30, tumor necrosis factor (TNF)-α and TNF receptors during primary HIV-1 infection: Correlation with HIV-1 RNA and the clinical outcome
11. High serum level of soluble CD30 in acute primary HIV-1 infection
12. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS
13. Cross-linking of CD30 induces HIV expression in chronically infected T cells
14. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals
15. Chemokine receptors: Gateways to inflammation and infection
16. Role of proinflammatory cytokines and β-chemokines in controlling HIV replication
17. A new classification for HIV-1
18. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
19. Do β-chemokines have clinical relevance in HIV infection?
20. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection
21. Immunocytochemical localization of the chemokine RANTES and MIP-1α within human platelets and their release during storage
22. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts
23. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation
24. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis
25. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells
26. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
27. Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects
28. Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: Possible pathogenetic role of immunoactivation mechanisms
29. Elevations in IFN-gamma, IL-5 and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: Association with autoantibodies and soluble CD30
30. The Th1/Th2 paradigm
31. Preferential expression of CD30 by human CD4+ T cells producing Th-2 type cytokines
32. In vivo relevance of CD30 in atopic dermatitis
33. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with atopic disorders and allergic contact dermatitis
34. High circulating levels of soluble CD30 correlate with impaired delayed-type hypersensitivity responses in HIV infected patients
35. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration
36. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells
37. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta and RANTES is associated with a type 1 immune response
38. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen elicited granulomatous inflammation
39. Selective diapedesis of Th1 cells induced by endothelial cell RANTES
40. Cytokine regulation of CC and CXC chemokine expression by human astrocytes
41. Interleukin-6 induces monocytes chemotactic protein-1 in peripheral blood mononuclear cells and in U937 cell line
42. Serum chemokine levels in patients with non-progressing HIV infection
43. Serum levels of RANTES and MIP-1α in HIV-positive longterm survivors and progressors patients
44. Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individuals
45. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1 alpha and RANTES correlate with virus load in human immunodeficiency virus infection
46. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals
47. Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals
48. Production of β-chemokines in human immunodeficiency virus infection: Evidence that high levels of macrophage inflammatory protein 1β are associated with a decreased risk of HIV disease progression
49. C-C chemokines, IL16, and soluble antiviral factor activity are increase in cloned T cells from subjects with long-term nonprogressive HIV infection
50. Chemokine production in HIV-seropositive long-term asymptomatic individuals